Candel Therapeutics (CADL) Institutional Ownership $7.91 -1.07 (-11.92%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$7.98 +0.07 (+0.83%) As of 03/3/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Candel Therapeutics (NASDAQ:CADL)CurrentInstitutional OwnershipPercentage13.93%Number ofInstitutional Buyers(last 12 months)35TotalInstitutional Inflows(last 12 months)$71.95MNumber ofInstitutional Sellers(last 12 months)6TotalInstitutional Outflows(last 12 months)$3.22M Get CADL Insider Trade Alerts Want to know when executives and insiders are buying or selling Candel Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CADL Institutional Buying and Selling by Quarter Candel Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Squarepoint Ops LLC19,311$168K0.0%+86.6%0.059% 2/17/2025 Nuveen Asset Management LLC68,226$592K0.0%+3.0%0.210% 2/17/2025 Maven Securities LTD51,731$449K0.0%N/A0.159% 2/17/2025 Millennium Management LLC31,626$275K0.0%+130.6%0.097% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.12,165$106K0.0%+12.4%0.037% 2/17/2025 Deutsche Bank AG31,522$274K0.0%+5,814.1%0.097% 2/17/2025 Bridgeway Capital Management LLC77,195$670K0.0%-4.2%0.238% 2/17/2025 Braidwell LP1,600,000$13.89M0.4%N/A4.926% 2/17/2025 Baker BROS. Advisors LP2,981,983$25.88M0.3%N/A9.181% 2/17/2025 Bank of America Corp DE66,811$580K0.0%+205.6%0.206% Get the Latest News and Ratings for CADL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Candel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025 BNP Paribas Financial Markets3,434$30K0.0%N/A0.011% 2/17/2025 Acorn Capital Advisors LLC1,939,644$16.84M9.2%N/A5.972% 2/14/2025 Northern Trust Corp165,021$1.43M0.0%+3.9%0.508% 2/14/2025 Oxford Asset Management LLP12,003$104K0.1%N/A0.037% 2/14/2025 Birchview Capital LP60,000$521K0.4%N/A0.185% 2/14/2025 Heights Capital Management Inc.30,000$260K0.1%N/A0.092% 2/14/2025 MetLife Investment Management LLC13,773$120K0.0%+9.7%0.042% 2/13/2025 Portolan Capital Management LLC753,745$6.54M0.4%N/A2.321% 2/13/2025 Barclays PLC34,317$297K0.0%+19.6%0.106% 2/13/2025 Russell Investments Group Ltd.3,753$33K0.0%+75.1%0.012% 2/13/2025 Wells Fargo & Company MN10,122$88K0.0%+63.6%0.031% 2/12/2025 Geode Capital Management LLC455,424$3.95M0.0%+1.4%1.402% 2/12/2025 JPMorgan Chase & Co.10,426$90K0.0%+15.2%0.032% 2/11/2025 LPL Financial LLC10,703$93K0.0%N/A0.033% 2/11/2025 Halter Ferguson Financial Inc.681,334$5.91M2.4%+123.7%2.098% 2/10/2025 Commonwealth Equity Services LLC41,098$357K0.0%N/A0.127% 2/6/2025 Charles Schwab Investment Management Inc.52,190$453K0.0%+11.6%0.161% 2/5/2025 Oppenheimer & Co. Inc.37,915$329K0.0%N/A0.117% 1/30/2025 Rhumbline Advisers26,272$228K0.0%+17.0%0.081% 1/30/2025 Vontobel Holding Ltd.19,000$165K0.0%-13.6%0.058% 1/15/2025 HB Wealth Management LLC87,300$696K0.0%+54.1%0.269% 12/26/2024 JPMorgan Chase & Co.9,051$63K0.0%-53.2%0.028% 11/19/2024 Barclays PLC28,688$199K0.0%+327.1%0.088% 11/16/2024 Geode Capital Management LLC448,997$3.11M0.0%+12.8%1.399% 11/15/2024 Barclays PLC28,688$199K0.0%+327.1%0.089% 11/15/2024 MML Investors Services LLC22,313$155K0.0%-69.6%0.070% 11/15/2024 State Street Corp492,005$3.41M0.0%+4.1%1.534% 11/15/2024 Atom Investors LP14,873$103K0.0%N/A0.046% 11/14/2024 MetLife Investment Management LLC12,558$87K0.0%N/A0.039% 11/13/2024 FMR LLC6,573$46K0.0%N/A0.020% Jeff Brown's Urgent March 17th Alert (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. 9/16/2024 Point72 DIFC Ltd4,927$31K0.0%N/A0.017% 9/16/2024 Cubist Systematic Strategies LLC26,121$162K0.0%N/A0.088% 8/14/2024 Cubist Systematic Strategies LLC26,121$162K0.0%N/A0.088% 8/14/2024 Point72 DIFC Ltd4,927$31K0.0%N/A0.017% 8/13/2024 Sands Capital Ventures LLC405,837$2.52M0.8%-50.0%1.364% 8/9/2024 Renaissance Technologies LLC20,600$128K0.0%-63.8%0.069% 8/1/2024 Rhumbline Advisers22,985$143K0.0%N/A0.077% 7/26/2024 Bank of New York Mellon Corp54,449$338K0.0%N/A0.183% 1/29/2024Baystate Wealth Management LLC76,910$113K0.0%-21.0%0.266% 5/10/2023 Resources Investment Advisors LLC.25,428$34K0.0%N/A0.088% 4/25/2023Baystate Wealth Management LLC105,854$143K0.0%N/A0.366% 11/14/2022 Point72 Asset Management L.P.403,131$1.27M0.0%-45.7%1.395% 5/6/2022 Empirical Asset Management LLC12,000$61K0.1%N/A0.042% 4/26/2022 Kestra Advisory Services LLC12,500$64K0.0%N/A0.044% 2/15/2022Northpond Ventures LLC1,935,215$15.13M5.3%N/A6.745% 2/15/2022 683 Capital Management LLC40,929$320K0.0%N/A0.143% 11/15/2021 Caas Capital Management LP50,000$542K0.0%N/A0.174% 11/15/2021 Franklin Resources Inc.1,125,000$12.20M0.0%N/A3.921% 11/9/2021BlackRock Inc.22,326$242K0.0%N/A0.078% (Data available from 1/1/2016 forward) CADL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CADL shares? During the previous two years, 42 institutional investors and hedge funds held shares of Candel Therapeutics. The most heavily invested institutionals were Baker BROS. Advisors LP ($25.88M), Acorn Capital Advisors LLC ($16.84M), Braidwell LP ($13.89M), Portolan Capital Management LLC ($6.54M), Halter Ferguson Financial Inc. ($5.91M), Geode Capital Management LLC ($3.95M), and State Street Corp ($3.41M).Learn more on CADL's institutional investors. What percentage of Candel Therapeutics stock is owned by institutional investors? 13.93% of Candel Therapeutics stock is owned by institutional investors. Learn more on CADL's institutional investor holdings. Which institutional investors have been buying Candel Therapeutics stock? Of the 37 institutional investors that purchased Candel Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Baker BROS. Advisors LP ($2.98M), Acorn Capital Advisors LLC ($1.94M), Braidwell LP ($1.60M), Portolan Capital Management LLC ($753.75K), Halter Ferguson Financial Inc. ($376.80K), Baystate Wealth Management LLC ($105.85K), and Birchview Capital LP ($60K). How much institutional buying is happening at Candel Therapeutics? Institutional investors have bought a total of 8,490,606 shares in the last 24 months. This purchase volume represents approximately $72.13M in transactions. Which Candel Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Candel Therapeutics stock in the last 24 months: Sands Capital Ventures LLC ($405.90K), MML Investors Services LLC ($51.06K), Renaissance Technologies LLC ($36.31K), Baystate Wealth Management LLC ($20.40K), JPMorgan Chase & Co. ($10.31K), Bridgeway Capital Management LLC ($3.40K), and Vontobel Holding Ltd. ($3K). How much institutional selling is happening at Candel Therapeutics? Institutional investors have sold a total of 530,375 shares in the last 24 months. This volume of shares sold represents approximately $3.25M in transactions. Related Companies KNSA Institutional Ownership DYN Institutional Ownership SNDX Institutional Ownership VIR Institutional Ownership NRIX Institutional Ownership PRAX Institutional Ownership ADPT Institutional Ownership DAWN Institutional Ownership ARDX Institutional Ownership GPCR Institutional Ownership This page (NASDAQ:CADL) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Candel Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Candel Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CADL Stock Alerts